Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maurizio Giuseppe Abrignani

Showing results (1-10 of 75) with videos related to

Pageof 8
Sort By:
Monaldi Archives for Chest Disease = Archivio Monaldi Per Le Malattie Del Torace|May 14, 2014
[Thromboembolic and hemorrhagic risk stratification in patients with atrial fibrillation. Part II: Hemorrhagic risk and guidelines recommendations]Maurizio Giuseppe Abrignani, Vincenzo Abrignani
Monaldi Archives for Chest Disease = Archivio Monaldi Per Le Malattie Del Torace|February 6, 2014
[Thromboembolic and hemorrhagic risk stratification in patients with atrial fibrillation. Part I: the thromboembolic risk]Maurizio Giuseppe Abrignani, Furio Colivicchi
Journal of Clinical Medicine|July 29, 2025
The Multidisciplinary Approach to GLP-1 RA and SGLT2 Inhibitors in Cardiometabolic Care: A New Era for Patients with Diabetes and Heart DiseaseFabiana Lucà, Maurizio Giuseppe Abrignani
Monaldi Archives for Chest Disease = Archivio Monaldi Per Le Malattie Del Torace|April 8, 2015
[The Health Department of Sicily "Regional recommendations for hospital discharge and communication with patients after admission due to a cardiologic event" decree]Maurizio Giuseppe Abrignani, Giovanni De Luca, Michele Gabriele, et al.
World Journal of Cardiology|April 18, 2022
Climatic influences on cardiovascular diseasesMaurizio Giuseppe Abrignani, Alberto Lombardo, Annabella Braschi, et al.
World Journal of Cardiology|September 29, 2023
Proton pump inhibitors and gastroprotection in patients treated with antithrombotic drugs: A cardiologic point of viewMaurizio Giuseppe Abrignani, Alberto Lombardo, Annabella Braschi, et al.
Giornale Italiano Di Cardiologia (2006)|October 4, 2018
[Prevention of cardioembolic events after intracranial hemorrhage]Maurizio Giuseppe Abrignani, Monica Carletti, Paolo Bovi, et al.
International Journal of Food Sciences and Nutrition|November 29, 2022
Effects of green tea catechins and exercise training on body composition parametersAnnabella Braschi, Rosalia Lo Presti, Maurizio Giuseppe Abrignani, et al.
World Journal of Cardiology|December 9, 2022
Time trends in antithrombotic therapy prescription patterns: Real-world monocentric study in hospitalized patients with atrial fibrillationMaurizio Giuseppe Abrignani, Alberto Lombardo, Annabella Braschi, et al.
Giornale Italiano Di Cardiologia (2006)|August 9, 2018
[Evaluation of cardiovascular risk and perioperative management of patients undergoing noncardiac surgery. Results of an ANMCO web survey]Annarita Pilleri, Maurizio Giuseppe Abrignani, Fabio Angeli, et al.
Pageof 8

Showing results (1-10 of 75) with videos related to

Sort By:
Pageof 8
Monaldi Archives for Chest Disease = Archivio Monaldi Per Le Malattie Del Torace|May 14, 2014
[Thromboembolic and hemorrhagic risk stratification in patients with atrial fibrillation. Part II: Hemorrhagic risk and guidelines recommendations]Maurizio Giuseppe Abrignani, Vincenzo Abrignani
Monaldi Archives for Chest Disease = Archivio Monaldi Per Le Malattie Del Torace|February 6, 2014
[Thromboembolic and hemorrhagic risk stratification in patients with atrial fibrillation. Part I: the thromboembolic risk]Maurizio Giuseppe Abrignani, Furio Colivicchi
Journal of Clinical Medicine|July 29, 2025
The Multidisciplinary Approach to GLP-1 RA and SGLT2 Inhibitors in Cardiometabolic Care: A New Era for Patients with Diabetes and Heart DiseaseFabiana Lucà, Maurizio Giuseppe Abrignani
Monaldi Archives for Chest Disease = Archivio Monaldi Per Le Malattie Del Torace|April 8, 2015
[The Health Department of Sicily "Regional recommendations for hospital discharge and communication with patients after admission due to a cardiologic event" decree]Maurizio Giuseppe Abrignani, Giovanni De Luca, Michele Gabriele, et al.
World Journal of Cardiology|April 18, 2022
Climatic influences on cardiovascular diseasesMaurizio Giuseppe Abrignani, Alberto Lombardo, Annabella Braschi, et al.
World Journal of Cardiology|September 29, 2023
Proton pump inhibitors and gastroprotection in patients treated with antithrombotic drugs: A cardiologic point of viewMaurizio Giuseppe Abrignani, Alberto Lombardo, Annabella Braschi, et al.
Giornale Italiano Di Cardiologia (2006)|October 4, 2018
[Prevention of cardioembolic events after intracranial hemorrhage]Maurizio Giuseppe Abrignani, Monica Carletti, Paolo Bovi, et al.
International Journal of Food Sciences and Nutrition|November 29, 2022
Effects of green tea catechins and exercise training on body composition parametersAnnabella Braschi, Rosalia Lo Presti, Maurizio Giuseppe Abrignani, et al.
World Journal of Cardiology|December 9, 2022
Time trends in antithrombotic therapy prescription patterns: Real-world monocentric study in hospitalized patients with atrial fibrillationMaurizio Giuseppe Abrignani, Alberto Lombardo, Annabella Braschi, et al.
Giornale Italiano Di Cardiologia (2006)|August 9, 2018
[Evaluation of cardiovascular risk and perioperative management of patients undergoing noncardiac surgery. Results of an ANMCO web survey]Annarita Pilleri, Maurizio Giuseppe Abrignani, Fabio Angeli, et al.
Pageof 8